JP2009543885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543885A5 JP2009543885A5 JP2009520962A JP2009520962A JP2009543885A5 JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5 JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- ibuprofen
- famotidine
- unit dosage
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/489,272 US20080020040A1 (en) | 2006-07-18 | 2006-07-18 | Unit dose form for administration of ibuprofen |
| US11/489,269 US20080021078A1 (en) | 2006-07-18 | 2006-07-18 | Methods and medicaments for administration of ibuprofen |
| US89737107P | 2007-01-24 | 2007-01-24 | |
| PCT/US2007/073716 WO2008011426A2 (en) | 2006-07-18 | 2007-07-17 | Methods and medicaments for administration of ibuprofen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009543885A JP2009543885A (ja) | 2009-12-10 |
| JP2009543885A5 true JP2009543885A5 (OSRAM) | 2011-08-11 |
Family
ID=38957561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520962A Pending JP2009543885A (ja) | 2006-07-18 | 2007-07-17 | イブプロフェンの投与のための方法および医薬 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP2043637B8 (OSRAM) |
| JP (1) | JP2009543885A (OSRAM) |
| AT (1) | ATE539747T1 (OSRAM) |
| AU (1) | AU2007275360B2 (OSRAM) |
| BR (1) | BRPI0714937A2 (OSRAM) |
| CA (1) | CA2657928C (OSRAM) |
| DK (1) | DK2043637T3 (OSRAM) |
| ES (1) | ES2380747T3 (OSRAM) |
| IL (1) | IL196425A (OSRAM) |
| NZ (1) | NZ574200A (OSRAM) |
| PL (1) | PL2043637T3 (OSRAM) |
| PT (1) | PT2043637E (OSRAM) |
| WO (1) | WO2008011426A2 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
| WO2008091957A2 (en) * | 2007-01-24 | 2008-07-31 | Horizon Therapeutics, Inc. | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| WO2013054352A1 (en) | 2011-08-17 | 2013-04-18 | Cadila Healthcare Limited | Pharmaceutical compositions of ibuprofen and famotidine |
| CA2889711A1 (en) | 2012-10-29 | 2014-05-08 | Arizona Board Of Regents On Behalf Of University Of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| JP2017519770A (ja) | 2014-06-18 | 2017-07-20 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ | Ｏｄｃ１遺伝子型に基づく癌腫の診断および処置 |
| MA43114A (fr) | 2015-10-30 | 2018-09-05 | Cancer Prevention Pharmaceuticals Inc | Formulation combinée à dose fixe d'éflornithine et sulindac |
| WO2017075576A1 (en) * | 2015-10-30 | 2017-05-04 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
| CN114096240A (zh) | 2019-05-17 | 2022-02-25 | 癌症预防制药股份有限公司 | 用于治疗家族性腺瘤性息肉病的方法 |
| US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| CA3159988C (en) * | 2020-07-15 | 2023-09-19 | Bernard Schachtel | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
| CN117320697A (zh) * | 2021-10-21 | 2023-12-29 | 韩和制药株式会社 | 包含孟鲁司特或其药学上可接受的盐和左西替利嗪或其药学上可接受的盐的稳定性提高的薄膜包衣片剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056143B2 (ja) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
| US4802924A (en) | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
| HU196775B (en) | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
| EP0663839A4 (en) * | 1992-09-29 | 1998-06-03 | Merck & Co Inc | Ibuprofen-h 2? antagonist combinations. |
| US5976578A (en) * | 1996-10-10 | 1999-11-02 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
| US6251945B1 (en) | 1999-01-14 | 2001-06-26 | Knoll Aktiengesellschaft | Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| DE10003757A1 (de) | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
| EP2260837A1 (en) * | 2001-06-01 | 2010-12-15 | Pozen, Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| DE10153934A1 (de) | 2001-11-06 | 2003-05-22 | Basf Ag | Verfahren zur Kristallisation von Profenen |
| WO2004064815A1 (en) * | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
| JP2006076956A (ja) * | 2004-09-10 | 2006-03-23 | Taiyo Yakuhin Kogyo Kk | 胃炎の治療・予防用配合剤 |
| WO2007012019A2 (en) * | 2005-07-18 | 2007-01-25 | Horizon Therapeutics, Inc. | Medicaments containing famotidine and ibuprofen and administration of same |
| DE102005049001A1 (de) | 2005-10-11 | 2007-04-12 | Basf Ag | Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen |
-
2007
- 2007-07-17 JP JP2009520962A patent/JP2009543885A/ja active Pending
- 2007-07-17 ES ES07813027T patent/ES2380747T3/es active Active
- 2007-07-17 EP EP07813027A patent/EP2043637B8/en not_active Not-in-force
- 2007-07-17 CA CA2657928A patent/CA2657928C/en not_active Expired - Fee Related
- 2007-07-17 DK DK07813027.5T patent/DK2043637T3/da active
- 2007-07-17 BR BRPI0714937-9A patent/BRPI0714937A2/pt not_active Application Discontinuation
- 2007-07-17 PT PT07813027T patent/PT2043637E/pt unknown
- 2007-07-17 WO PCT/US2007/073716 patent/WO2008011426A2/en not_active Ceased
- 2007-07-17 PL PL07813027T patent/PL2043637T3/pl unknown
- 2007-07-17 AT AT07813027T patent/ATE539747T1/de active
- 2007-07-17 EP EP12150096A patent/EP2438919A1/en not_active Withdrawn
- 2007-07-17 NZ NZ574200A patent/NZ574200A/en not_active IP Right Cessation
- 2007-07-17 AU AU2007275360A patent/AU2007275360B2/en not_active Ceased
-
2009
- 2009-01-11 IL IL196425A patent/IL196425A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009543885A5 (OSRAM) | ||
| JP2006504795A5 (OSRAM) | ||
| JP2022180461A5 (OSRAM) | ||
| Eisen | Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis | |
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2009536147A5 (OSRAM) | ||
| JP2010525050A5 (OSRAM) | ||
| JP2013231087A5 (OSRAM) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2009525343A5 (OSRAM) | ||
| JP2012031131A5 (OSRAM) | ||
| MX2009000730A (es) | Liberacion controlada de formulaciones y metodos asociados. | |
| HRP20130057T1 (hr) | Lijeäśenje progresivne neurodegenerativne bolesti ibudilastom | |
| JP2012515184A5 (OSRAM) | ||
| JP2013505205A5 (OSRAM) | ||
| JP2009501801A5 (OSRAM) | ||
| JP2012500786A5 (OSRAM) | ||
| JP2011527301A5 (OSRAM) | ||
| JP2019517542A5 (OSRAM) | ||
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| JP2013541583A5 (OSRAM) | ||
| Bhaskar et al. | Comparison of transdermal diclofenac patch with oral diclofenac as an analgesic modality following multiple premolar extractions in orthodontic patients: a cross over efficacy trial | |
| JP2012533559A5 (OSRAM) | ||
| AR105184A1 (es) | Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos | |
| JP2016530291A5 (OSRAM) |